Mª DEL CARMEN
VIDAL PAN
Profesora titular de universidade
Universitat de Barcelona
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Universitat de Barcelona (13)
2020
2018
-
Validating a breast cancer score in Spanish women. The MCC-Spain study
Scientific Reports, Vol. 8, Núm. 1
2017
-
Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case–control study
International Journal of Cancer, Vol. 141, Núm. 1, pp. 83-93
2002
-
Genotypic and phenotypic resistance patterns in early-stage HIV-1-infected patients failing initial therapy with stavudine, didanosine and nevirapine
Antiviral Therapy, Vol. 7, Núm. 4, pp. 283-287
2001
2000
-
Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus- infected patients receiving antiretroviral therapy
Clinical Infectious Diseases, Vol. 30, Núm. 2, pp. 392-394
1999
1998
-
Changes in HIV-1 RNA viral load following tuberculin skin test [7]
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
-
Lack of evidence of a stable viral load set-point in early stage asymptomatic patients with chronic HIV-1 infection
AIDS, Vol. 12, Núm. 11, pp. 1285-1289
-
Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, Vol. 19, Núm. 1, pp. 55-60
1997
-
Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 x 106/l
AIDS, Vol. 11, Núm. 1, pp. 53-57
1996
-
A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals
Antiviral Therapy, Vol. 1, Núm. 2, pp. 105-112